Abstract : The current study was framed to evaluate the anti diabetic activity of falvonoids isolated from the leaves and rhizomes of Rhus mysorensis. Anti diabetic effects of these flavonoids were screened using in vitro and in vivo models. The in vitro anti diabetic activity was screened using enzyme assay. The in vivo anti diabetic activity was screened in albino diabetic induced rats. The inhibition of α-amylase and α-glucosidase by the isolated compounds were found in concentration dependent manner. The high inhibition was found at 150 mg/mL concentration. Among the compounds screened, 2-(3,4-dihydroxyphenyl)-hydroxy-4H-chromen-4-one and 5,6,7-trihydroxy-2-phenyl-4H-chromen-4-one showed significant enzyme inhibitory effects. the fasting blood glucose levels are increased 0 hour to 7 days of treatment. Animals of the groups VII, VIII, IX, XIII, XIV,-hydroxy-4H-chromen-4-one and 5,6,7-trihydroxy-2-phenyl-4H-chromen-4-one at 100, 150, 200 mg/mL) significant reduction in the blood glucose levels after prolonged treatment (P<0.001). we noticed that compounds 2-(3,4-dihydroxyphenyl)-hydroxy-4H-chromen-4-one and 5,6,7-trihydroxy-2-phenyl-4H-chromen-4-one started to reduce the glucose levels significantly from 14 days of treatment was comparable to blood glucose levels of animals treated with standard drug glibenclamide.
I. Introduction
In more recent history the use of plants as medicines has involved the isolation of active compounds involves in the development of plant derived drugs [1] . There are several bioactive compounds isolated from the plants are currently in clinical trials are extensively use as Ayurvedic medicine for the treatment of diabetic mellitus [2] . Approximately, 108 plant species belonging to 56 families and 400 plants derived compounds are playing a major role in delaying diabetic complications [3] [4] . Diabetes has been identified as an oxidative stress based disorder generated by an imbalance between the cellular production of reactive oxygen species and the counteracting antioxidant mechanisms by body's natural antioxidants [5] . Studies have suggested that oxidative stress are enacted in systemic inflammation, endothelial dysfunction, impaired secretion of pancreatic β-cells and glucose utilization in peripheral tissues that lead to long-term secondary complications [6] . The current study was framed to evaluate the anti diabetic activity of falvonoids isolated from the leaves and rhizomes of Rhus mysorensis (Data of compound isolation was not shown here). "Rhus mysorensis" "Rhous ancient Greek name for sumac, the genus Rhus refers to various shrubs or small trees. A small aromatic, often gregarious shrub with a thin brown bark and very spinous branches, Leaves trifoliate or rarely Penta foliate branch lets woolly at apices, spines up to 1.5 cm long. Leaf arrangement Alternate Spiral Leaf ShapeObovate Leaf apex Obtuse-apiculate often emarginated Leaf Base -Cuneate. Leaf Margin -sinous. It is found in dry slopes and exposed rocks from 400 to 800 mts common in India Grow on stony regions, found in hot dry places in Punjab, Haryana, Rajasthan, Gujarat, Karnataka, Andhraprades, Telangana and the Western Peninsula, Common in foot hills, Scrub jungles to 900 m. North west India to the peninsular India. Anti diabetic effects of these flavonoids were screened using in vitro and in vivo models. The in vitro anti diabetic activity was screened using enzyme assay. The in vivo anti diabetic activity was screened in albino diabetic induced rats [7] .
II. Material And Methods
2.1 Anti-diabetic Activity 2.1.1 In vitro enzyme inhibitory effects Rhus mysorensis crude extracts a. Alpha-amylase inhibitory activity Alpha amylase (EC 3.2.1.1) inhibitory activities of compounds isolated from Rhus mysorensis extracts was determined according to the method described by elsewhere with slight modification [8] . Briefly 0.25 μl of urinary alpha amylase (5 U/ml) was pre-incubated with various concentrations (50, 75, 100, 125, 150 µg/mL) of isolated compounds for 15 min at 37 o C water bath. The reaction was started by addition of 0.2 μl of 0.5% potato starch dissolved in 20mM phosphate buffer, pH 6.9. The reaction mixture was then incubated at 37 o C for 20 
b. Alpha glucosidase inhibitory activity
The effect of the plant extracts on alpha glucosidase activity was determined according to the chromogenic method described by by elsewhere [8] . The substrate solution p-nitrophynyl glucopyranoside (pNPG) was prepared in 20 mM phosphate buffer, pH 6.9. Five units of alpha glucosidase (E.C. 3.2.1.20) were pre-incubated with various concentrations (50, 75, 100, 125, 150 µg/mL) of flavonoids isolated from leaves and rhizome extract of Rhus mysorensis for 15 minutes. Three millimolar (pNPG) as a substrate dissolved in 20mM phosphate buffer, pH 6.9 was then added to start the reaction. The reaction mixture was incubated at 37 o C for 20 minutes and stopped by adding 2 ml of 0.1 M Na 2 CO 3 . The α-glucosidase activity was determined by measuring the yellow colored p-nitrophenol released from pNPG at 400 nm. The results were expressed as percentage of the blank control. 
In vivo anti-diabetic activity

Induction of diabetes
Streptozotocin was purchased from Sisco Research laboratories Pvt. Ltd. Mumbai, India and was freshly dissolved in 0.1 M citrate buffer (pH = 4.5) at the dose of 50 mg/kg body weight and injected intraperitoneally within 15 min of dissolution in a vehicle volume of 0.4 ml with 1 ml of tuberculin syringe fitted with 24 gauge needle, whereas normal control group was given citrate buffer only (0.4 ml). Diabetes was confirmed by the determination of fasting glucose concentration on the third day post administration of streptozotocin
Body weight
Each animal was weighed daily using mouse balance (Adventurer SL, Switzerland), for the period of four weeks which the experiment lasted. After 28 days of treatment, experiments were terminated and observations were noted.
Effects on blood glucose levels
At the end of the experiment the blood (1 ml) was collected from the orbital sinus into heparin coated bottles and immediately used for the determination of glucose using a glucometer (Vivek et al., 2007).
Experimental design for the anti diabetic effects of the isolated compounds in albino rats S.No *Group Treatment 1 I Rats in this group which served as normal control and were given only distilled water daily 2 II Rats in this group are STZ induced diabetic rats and served as diabetic control and were given distilled water only 3 III Rats of this group are STZ induced and were treated orally with glibenclamide used as a reference drug and was administered orally at 4 mg/kg as a suspension in 1% w/v CMC daily for 28 days, once in a day. 4 IV Rats of this group are STZ induced diabetic rats and were treated orally with 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one at the dose of 100 mg/kg body weight daily for 28 days, once a day. 5 V Rats of this group are STZ induced diabetic rats and were treated orally with 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one at the dose of 150 mg/kg body weight daily for 28 days, once a day. 6 VI Rats of this group are STZ induced diabetic rats and were treated orally with 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one at the dose of 200 mg/kg body weight daily for 28 days, once a day 7 VII Rats of this group are STZ induced diabetic rats and were treated orally with 2-(3,4-dihydroxyphenyl)-hydroxy-4H-chromen-4-one at the dose of 100 mg/kg body weight daily for 28 days, once a day. 8 VIII Rats of this group are STZ induced diabetic rats and were treated orally with 2-(3,4-dihydroxyphenyl)-hydroxy-4H-chromen-4-one at the dose of 150 mg/kg body weight daily for 28 days, once a day. 9 IX Rats of this group are STZ induced diabetic rats and were treated orally with 2-(3,4-dihydroxyphenyl)-hydroxy-4H-chromen-4-one at the dose of 200 mg/kg body weight daily for 28 days, once a day. 10 X Rats of this group are STZ induced diabetic rats and were treated orally with 2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-4H-chromen-4-one at the dose of 100 mg/kg body weight daily for 28 days, once a day. 11 XI Rats of this group are STZ induced diabetic rats and were treated orally with 2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-4H-chromen-4-one at the dose of 150 mg/kg body weight daily for 28 days, once a day. 
III. Results
Inhibitory activities of isolated compounds on α-amylase and α-glucosidase
The inhibition of α-amylase and α-glucosidase by the isolated compounds were found in concentration dependent manner. The high inhibition was found at 150 mg/mL concentration. Among the compounds screened, 2 
Measurement of body weight of animals
At the termination period (28 days), we have determined the body weight of animals. During our studies, we observed that animas of all groups (I-XV expect group-II-diabetic control) showed remarkable weight gain (Table 1) (Table 1) .
Determination of blood Glucose levels
According to data shown in table 2, the fasting blood glucose levels are increased 0 hour to 7 days of treatment. Animals of the groups VII, VIII, IX, XIII, XIV, XV (Diabetic control +2-(3,4-dihydroxyphenyl)-hydroxy-4H-chromen-4-one and 5,6,7-trihydroxy-2-phenyl-4H-chromen-4-one at 100, 150, 200 mg/mL) significant reduction in the blood glucose levels after prolonged treatment (P<0.001). we noticed that compounds 2-(3,4-dihydroxyphenyl)-hydroxy-4H-chromen-4-one and 5,6,7-trihydroxy-2-phenyl-4H-chromen-4-one started to reduce the glucose levels significantly from 14 days of treatment was comparable to blood glucose levels of animals treated with standard drug glibenclamide. The results are found in concentration manner. The hiher concentrations of compounds 2-(3,4-dihydroxyphenyl)-hydroxy-4H-chromen-4-one and 5,6,7-trihydroxy-2-phenyl-4H-chromen-4-one reduced the glucose levels of 80% (151.8±1.1 and 153.2±1.7 at 150 mg/mL). Animals of group III (Positive control) showed consistent decrease in the blood glucose levels by 95% comparing to the blood glucose levels of normal control rats. On the other hand, there is decrease in the blood glucose levels of group II (Diabetic control) ( Table 2 ).
IV. Discussion
In the present study, we have demonstrated the anti diabetic activities of flavonoids isolated from Rhus mysorensis (isolation data was not shown). The screening was performed in in vitro and in vivo anti diabetic methods. The in vitro anti diabetic assay was carried out using enzyme assay. The in vivo anti diabetic activity was done in diabetic induced albino rats. During our studies, we observed that, among four flavonoids tested, two are more significantly showed enzyme inhibition and lowered the blood glucose levels and comparable to the standard drug showed for a period of 4 weeks. It clear noted that, these flavonoids possess a common mechanism for the inhibition of both enzymes because of structural similarities of both enzymes [9] . Another mechanism exhibited by the compounds that delay or inhibit the mechanism of digestion [10] . Antihyperglycemic activities of compounds tested in streptozoticin induced rats showed good activity on reduction of blood glucose levels. Initially, body weight and glucose levels of animals were found to be increased till the 7th day after streptozotocin administration and thereafter, from 7th day, we noticed a drastic decrease in blood glucose levels of animals treated with treated with compounds with various concentrations. On the other hand body weight of animals also shown in increase. In concern to hazardous effects shown by synthetic drugs the naturally derived drugs gained movement to replace the chemically derived drugs. Therefore, scientists DOI: 10.9790/264X-03033742 www.iosrjournals.org 40 | Page increased focused for isolation of naturacetuicals which are safe and affordable. Contemporary compounds isolated from plants which are currently use as anti diabetic drugs are salacinol, kotalanol, glucoside jamboline, phytol, myoinositol, scyllitol, pryones, stigmat-4-en-3-one, cholest-4-en-3-one. These compounds exhibit different modes of action that include inhibition of intestinal amylase-α-glucosidase, increase of β-cell stimulation, increase in number of insulin receptors, increase in insulin receptor binding affinity to the released insulin, fighting against free radicals to decrease cell damage and decrease of hepatic glucose by decreasing gluconeogenesis and glycogenolysis [11] . By the literature of survey, we found that, the crude root extracts of Rhus mysorensis showed consequential antidiabetic activity in wister rats by decreased the blood glucose levels [12] . Till the date we don't found only little literature on anti diabetic activities of crude extracts or isolated compounds from the Rhus mysorensis. Therefore, here under we consider the anti diabetic activities of other species of Rhus family. Rhus coriaria, chirindensis, verniciflua crude extracts reported to possess significant In vitro and In vivo hypoglycemic activities [13] [14] [15] . The results of this report could become the first reports on the anti diabetic activity of flavonoids isolated from the Rhus mysorensis. 
V. Conclusion
Basing on our studies, we conclude that the compounds isolated from the Rhus mysorensis exhibit the anti diabetic activity tested in vitro and in vivo. However, the further studies are required to use these compounds to treat for the various forms of diabetic mellitus.
